INTRODUCTION
As described in previous publications, Annals of Emergency Medicine and Academic Life in Emergency Medicine (ALiEM) launched a shared initiative to increase awareness of key emergency medicine literature, increase the speed of knowledge translation, and provide an educational resource to teach critical appraisal to emergency physicians. 1, 2 The Global Emergency Medicine Journal Club combines an academic blog's experience in educational discussions on social media with Annals' experience with critical appraisal and evidence-based medicine. In this third Global Emergency Medicine Journal Club, we featured the 2013 article by Nielsen et al. 3 Before the launch of the Global Emergency Medicine Journal Club, the online discussion of the Nielsen et al 3 targeted temperature management article was extensive. 3 Its Altmetric score 4 of 470 on January 20, 2014, placed it within the top 50 highest-rated articles ever published in the New England Journal of Medicine and the 99th percentile of all articles rated by the service. 5 Multiple prominent clinician-educators declared that the article was practice-changing because of its relatively large study population and robust methodology.
MATERIALS AND METHODS
The Annals editors selected the article for the third edition of the Global Emergency Medicine Journal Club collaboration with ALiEM. 6 Three facilitators were chosen for their expertise in critical appraisal (D.R.) and medical education (B.T., M.L.). Two were experienced bloggers (BoringEM and ALiEM, B.T.; ALiEM, M.L.) and have a broad, international reach on Twitter, with more than 1,600 (B.T.; @Brent_Thoma) and 5,000 (M.L.; @M_Lin) followers at the discussion.
Before selection of the Global Emergency Medicine Journal Club questions, an inventory of the previous social media discussions on the targeted temperature management trial was taken. The Boolean search term "targeted temperature management" was entered into Google and FOAMSearch 7 on March 10, 2014. The first 100 results of each engine and any blog posts or podcasts linked to within them were reviewed. All blog posts and podcasts discussing the trial were compiled. Consensus was developed on the 4 questions between the Annals editors and authors according to the results of this review and the questions posed in the March 2014 edition of the Annals journal club. 6 The facilitators' goal during the Global Emergency Medicine Journal Club was to encourage discussion and reflection on 4 preselected discussion questions and 1 poll question about current clinical practices. On March 25, 2014, a live Google Hangout videocast was used to host a discussion between Dr. Niklas Nielsen (Lund University, Sweden), the lead author of the targeted temperature management article, and representatives from ALiEM and Annals. The questions for the videocast were developed collaboratively by the participants according to the Twitter and blog discussions.
The Global Emergency Medicine Journal Club was hosted on the ALiEM Web site, with comments moderated on the blog and Twitter. The format of the discussion was similar to that of the November 2013 1 and January 2014 2 Global Emergency Medicine Journal Club. Promotion for the Journal Club included notices on the ALiEM and Annals Web sites, Facebook pages, and Googleþ pages. Ongoing promotion occurred throughout the week, with tweets including the #ALiEMJC hashtag from the Annals' and facilitators' Twitter accounts. Google Analytics, the ALiEM Social Media Widget, YouTube Analytics, and Symplur were used to track metrics for viewership, social media, the videocast, and Twitter, respectively. The number of comments and words per comment in the blog discussion were calculated, excluding the initial comments by the facilitators and all references. All analytics were recorded during a 14-day period. The Twitter and blog discussions on each question were analyzed with a qualitative thematic analysis by one author (B.T.) and member checked by a second (D.R.).
RESULTS
The inventory of blog posts and podcasts previously discussing the targeted temperature management trial 3 is presented in Table 1 . There were 18 blog posts and 7 podcasts, of which 17 were published within 1 week of the online publication of the targeted temperature management trial. 3 The analytics data for the Global Emergency Medicine Journal Club, which occurred between March 20 and April 2, 2014, are summarized in Table 2 . The geographic distribution of participants is outlined in Figure 1 .
SUMMARY OF THE GLOBAL EMERGENCY MEDICINE JOURNAL CLUB DISCUSSION
A vigorous discussion surrounding the 4 Global Emergency Medicine Journal Club questions occurred on Twitter and the ALiEM blog ( Figure 2 ). It is summarized below, and a full transcript is archived at http://academiclifeinem.com/aliem-annals-em-journalclub-targeted-temperature-management/.
Q1: If you were creating a cardiac arrest protocol in your hospital, what would you set for the target temperature? Do you think the temperature or the protocol is more important for survival?
The difference in the results between the targeted temperature management trial and the previous hypothermia trials was attributed to hyperthermia and unbalanced care between the control and treatment groups in the trials by Bernard et al 8 and Hypothermia After Cardiac Arrest 9 trials. As illustrated by the results of our poll (Table 3) , the majority of the readers believed that the weight of the evidence supports a target of 36 C (96.8 F). The discussion participants echoed the sentiments expressed in the poll, with some caveats. A notable proponent against changing current practices to 36 C (96.8 F) was Dr. Hangyul Chung-Esaki (University of California, San Francisco, by blog comment), who noted that the 33 C (91.4 F) group may have been sicker, active cooling was needed in both groups, and there is still uncertainty surrounding optimal timing and length for cooling.
Many of the participants registered concerns about patients inadvertently reaching higher temperatures when 36 C (96.8 F) is targeted. Dr. Joe Bednarczyk (University of Manitoba, Canada, by blog comment) noted that "in the targeted temperature management trial caregivers were in a rigid protocol under the microscope of a study setting. Real world temperature control may be different." Several participants echoed Dr. Chris Bond's (University of Calgary, Canada, by blog comment) sentiments when he said that this trial cannot allow "us to become lackadaisical about preventing hyperthermia" because maintaining 36 C (96. Wong (Massachusetts General Hospital, by blog comment) and Salim Rezaie (University of Texas, San Antonio, by blog comment) referenced the similarities between this trial and the recent ProCESS trial on sepsis care. 10 In both, the intervention was a multifactorial protocol, making it difficult to distinguish which factors resulted in the benefit or whether it was solely the result of the increased attention that patients under methodical care received. Dr. Ryan Radecki (University of Texas, Houston, by blog comment) called for further research in this area, noting that the effect of sedation duration, sedation medication, and simple hyperthermia management has yet to be examined in this population.
Q2: The authors noted the inability to blind the critical care practitioners; however, they were able to blind the assessors providing follow-up neurologic examination. Were the methods used to eliminate the risk of critical care provider bias sufficient?
Insufficient blinding can bias results. However, it is not possible to blind care providers to an essential vital sign, particularly when they will need to change care to reach a particular target value. The general sentiment was that the blinding had been as rigorous as possible. Ms. Eve Purdy (Queen's University, Canada, by blog comment) noted that any biases of the practitioners would have likely favored the 33 C (91.4 F) group. The fact that no difference was found implies that there was minimal bias or that the 33 C (91.4 F) group should have had worse outcomes.
Although the intensivists were not blinded to the target temperature, blinding was incorporated in several ways. Dr. Wong was impressed that the authors were blinded while writing the study, whereas Dr. Bednarczyk noted that blinded neurologists conducted the neurologic assessment before the withdrawal of care. Dr. David Easton (University of Manitoba, Canada, by Twitter) thought that these other blinding protocols are perhaps robust enough to compensate for the nonblinded critical care practitioners (Figure 3) . Q3: Do you think there is a subgroup of patients who will benefit from cooling to lower temperatures (ie, 32 C [89.6 F] to 34 C [93.2 F])? The consensus was that with the information that we currently have available, we do not know, because this trial was not powered to find differences in the subgroups. Dr. Radecki noted that cardiac arrest is a heterogenous disease. A single study to investigate subgroups according to cardiac arrest causes and out-of-hospital interventions would be too enormous and expensive to conduct.
Several participants, including Dr. Jean Baptiste Lascarrou (Centre Hospitalier Départemental, France, by blog comment), the study chair of the French Hypothermia After Cardiac Arrest in Non Shockable Rhythm trial 11 assessing therapeutic hyperthermia in nonshockable rhythms, thought that a sicker patient population (eg, those with asystole) may benefit more from lower temperatures. However, Dr. Daniel Runde (University of California, Los Angeles, by Twitter) pointed out that if there was a subgroup that fared better in this trial, there must be a subgroup that fared worse to balance the results. ) subgroups and found no difference in mortality. However, these hazard ratios contained wide confidence intervals and the study was not powered to find a difference in these subgroups. Table 3 . Poll responses by Journal Club participants to the question, which of the following statements is true for you and your institution's protocol on patients presenting with out-of-hospital cardiac arrest?
We should target T¼36 C (96.8 F). My institution's OOHCA protocol has not changed to 36 C (96.8 F).
(54.3)
We should target T¼33 C (91.4 F). My institution's OOHCA protocol has not changed to 36 C (96.8 F).
14 (20.0)
We should target T¼36 C (96.8 F). My institution's OOHCA protocol has changed to 36 C (96.8 F).
(7.1)
We should target T¼36 C (96.8 F). My institution's OOHCA protocol is being changed to 36 C (96.8 F).
We should target T¼36 C (96.8 F). My institution does not have an OOHCA protocol.
(5.7)
We should target T¼33 C (91.4 F). My institution does not have an OOHCA protocol. Q4: The authors examined the primary outcome of survival time and followed patients up to the end of the trial (ie, 180 days after the enrollment of the last patient) and powered the study to this outcome. The trial was designed as a superiority trial to detect a 20% reduction in the hazard ratio for death with hypothermia at 33 C (91.4 F) versus a control group at 36 C (96.8 F). Was the study appropriately powered for this outcome? How would the power calculations change if the study design were a noninferiority trial of relative normothermia at 36 C (96.8 F) versus hypothermia at 33 C (91.4 F)? This trial was a superiority trial powered to detect a difference in the primary outcome of mortality. Drs. Chan and Wong noted that neurologically intact survival would probably have been a more clinically relevant outcome. However, because finding a significant difference in neurologic outcome would require less power than finding a difference in overall mortality, the study had adequate power to accurately detect differences in this secondary outcome and did not.
The power calculations for the targeted temperature management trial were predicated on the results of the Hypothermia After Cardiac Arrest 9 trial and that by Bernard et al. 8 An absolute risk reduction of approximately 11% (which was exceeded by both of these 2002 studies 8, 9 ) would have been needed to find a significant difference. The power needed for this comparison was met and no significant difference was found, allowing us to say with confidence that the 33 C (91.4 F) group did not have an 11% absolute risk reduction in mortality relative to the 36 C (96.8 F) group.
Dr. Rolston explained that for outcomes such as mortality, the acceptable noninferiority margin (the amount of difference that would be considered clinically insignificant) should be very small, with an absolute risk reduction of less than 1% (corresponding with an number needed to treat of >100). Confidently demonstrating this much smaller risk reduction in a noninferiority trial would require a substantially larger population. In this case, Dr. Rolston calculated that a sufficiently powered noninferiority trial with a 1-sided a of .025, power of 90%, and noninferiority margin of 1% to 2% to be somewhere between 25,900 and 105,594 patients. Dr. Sandy Dong (University of Alberta, Canada, by Twitter) came to a similar conclusion without performing the calculation and added that there are no guarantees with regard to certainty (Figure 4) . This is an important distinction to understand because it means that the appropriate conclusion from this trial is not that targeting 33 C (91.4 F) and 36 C (96.8 F) are the same, but that they were not 11% different. Dr. Lascarrou criticized the design and discussions about the targeted temperature management trial for this reason, noting that the researchers "built a superiority trial with an equivalence way of thinking." In general, the participants thought that this was a very difficult concept to understand comprehensively and suggested several excellent resources.
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The participants were polled about their thoughts and their institution's protocol on patients presenting with out-of-hospital cardiac arrest. Of 70 responses, a slight majority (54.3%) indicated that we should target 36 C (96.8 F) but that their protocol had not been changed. The full results are presented in Table 3 . F) for out-of-hospital cardiac arrest patients. Overall, the targeted temperature management trial was thought to be extremely well designed and made a substantial contribution to the literature. Further study of subgroups that may benefit from targeting lower temperatures for postarrest patients is warranted. From an educational perspective, this study provides an excellent basis for discussions about trial design, and particularly the importance of distinguishing between superiority and noninferiority study designs. It was able to attract 1,189 unique readers from 60 countries, using social media modalities that included a medical education blog and Twitter.
